...
imnn-img

Imunon Inc, Common Stock

IMNN

NAQ

$0.8402

-$0.06

(-6.67%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$13.04M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
332.13K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.13
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.48 L
$3.65 H
$0.8402

About Imunon Inc, Common Stock

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIMNNSectorS&P500
1-Week Return-1.75%-1.8%-0.77%
1-Month Return1.39%-3.48%0.71%
3-Month Return-23.96%-7.2%8.81%
6-Month Return-34.36%-1.54%12.32%
1-Year Return-3.43%8.39%30.57%
3-Year Return-91.11%6.07%29.21%
5-Year Return-96.27%44.07%91.95%
10-Year Return-99.83%106.3%196.04%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue500.00K500.00K500.00K500.00K125.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":25,"profit":true}]
Cost of Revenue13.07M11.34M702.92K731.63K720.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":86.83,"profit":true},{"date":"2021-12-31","value":5.38,"profit":true},{"date":"2022-12-31","value":5.6,"profit":true},{"date":"2023-12-31","value":5.51,"profit":true}]
Gross Profit(12.57M)(10.84M)(202.92K)(231.63K)(720.00K)[{"date":"2019-12-31","value":-1256530900,"profit":false},{"date":"2020-12-31","value":-1084481900,"profit":false},{"date":"2021-12-31","value":-20291800,"profit":false},{"date":"2022-12-31","value":-23162900,"profit":false},{"date":"2023-12-31","value":-72000500,"profit":false}]
Gross Margin(2513.06%)(2168.96%)(40.58%)(46.33%)(576.00%)[{"date":"2019-12-31","value":-2513.06,"profit":false},{"date":"2020-12-31","value":-2168.96,"profit":false},{"date":"2021-12-31","value":-40.58,"profit":false},{"date":"2022-12-31","value":-46.33,"profit":false},{"date":"2023-12-31","value":-576,"profit":false}]
Operating Expenses21.07M18.99M21.51M25.42M20.31M[{"date":"2019-12-31","value":82.86,"profit":true},{"date":"2020-12-31","value":74.68,"profit":true},{"date":"2021-12-31","value":84.6,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.89,"profit":true}]
Operating Income(20.57M)(18.49M)(21.01M)(24.92M)(21.03M)[{"date":"2019-12-31","value":-2056547300,"profit":false},{"date":"2020-12-31","value":-1848641200,"profit":false},{"date":"2021-12-31","value":-2100700000,"profit":false},{"date":"2022-12-31","value":-2492200000,"profit":false},{"date":"2023-12-31","value":-2103043000,"profit":false}]
Total Non-Operating Income/Expense947.05K(6.07M)(1.70M)(17.12M)1.09M[{"date":"2019-12-31","value":87.25,"profit":true},{"date":"2020-12-31","value":-559.09,"profit":false},{"date":"2021-12-31","value":-156.36,"profit":false},{"date":"2022-12-31","value":-1576.89,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(18.67M)(23.33M)(22.15M)(37.47M)(20.80M)[{"date":"2019-12-31","value":-1866800700,"profit":false},{"date":"2020-12-31","value":-2332938400,"profit":false},{"date":"2021-12-31","value":-2215300000,"profit":false},{"date":"2022-12-31","value":-3746500000,"profit":false},{"date":"2023-12-31","value":-2079536200,"profit":false}]
Income Taxes(1.82M)(1.85M)(1.38M)(1.57M)(1.28M)[{"date":"2019-12-31","value":-181647400,"profit":false},{"date":"2020-12-31","value":-184582300,"profit":false},{"date":"2021-12-31","value":-138400000,"profit":false},{"date":"2022-12-31","value":-156700000,"profit":false},{"date":"2023-12-31","value":-128038500,"profit":false}]
Income After Taxes(16.85M)(21.48M)(20.77M)(35.90M)(19.51M)[{"date":"2019-12-31","value":-1685153300,"profit":false},{"date":"2020-12-31","value":-2148356100,"profit":false},{"date":"2021-12-31","value":-2076900000,"profit":false},{"date":"2022-12-31","value":-3589800000,"profit":false},{"date":"2023-12-31","value":-1951497700,"profit":false}]
Income From Continuous Operations(16.85M)(21.48M)(20.77M)(35.90M)(27.86M)[{"date":"2019-12-31","value":-1685153300,"profit":false},{"date":"2020-12-31","value":-2148356100,"profit":false},{"date":"2021-12-31","value":-2076925000,"profit":false},{"date":"2022-12-31","value":-3589800000,"profit":false},{"date":"2023-12-31","value":-2785951900,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(16.85M)(21.48M)(20.77M)(35.90M)(19.51M)[{"date":"2019-12-31","value":-1685153300,"profit":false},{"date":"2020-12-31","value":-2148356100,"profit":false},{"date":"2021-12-31","value":-2076900000,"profit":false},{"date":"2022-12-31","value":-3589800000,"profit":false},{"date":"2023-12-31","value":-1951497700,"profit":false}]
EPS (Diluted)(11.10)(10.05)(6.77)(5.17)(2.18)[{"date":"2019-12-31","value":-1110,"profit":false},{"date":"2020-12-31","value":-1005,"profit":false},{"date":"2021-12-31","value":-677,"profit":false},{"date":"2022-12-31","value":-517,"profit":false},{"date":"2023-12-31","value":-218,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IMNN
Cash Ratio 1.89
Current Ratio 2.30

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IMNN
ROA (LTM) -67.08%
ROE (LTM) -148.12%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IMNN
Debt Ratio Lower is generally better. Negative is bad. 0.43
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.57

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IMNN
Trailing PE NM
Forward PE NM
P/S (TTM) 17.94
P/B 1.59
Price/FCF NM
EV/R 4.00
EV/Ebitda 0.91

FAQs

What is Imunon Inc share price today?

Imunon Inc (IMNN) share price today is $0.8402

Can Indians buy Imunon Inc shares?

Yes, Indians can buy shares of Imunon Inc (IMNN) on Vested. To buy Imunon Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMNN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Imunon Inc be purchased?

Yes, you can purchase fractional shares of Imunon Inc (IMNN) via the Vested app. You can start investing in Imunon Inc (IMNN) with a minimum investment of $1.

How to invest in Imunon Inc shares from India?

You can invest in shares of Imunon Inc (IMNN) via Vested in three simple steps:

  • Click on Sign Up or Invest in IMNN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Imunon Inc shares
What is Imunon Inc 52-week high and low stock price?

The 52-week high price of Imunon Inc (IMNN) is $3.65. The 52-week low price of Imunon Inc (IMNN) is $0.48.

What is Imunon Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Imunon Inc (IMNN) is

What is Imunon Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Imunon Inc (IMNN) is 1.59

What is Imunon Inc dividend yield?

The dividend yield of Imunon Inc (IMNN) is 0.00%

What is the Market Cap of Imunon Inc?

The market capitalization of Imunon Inc (IMNN) is $13.04M

What is Imunon Inc’s stock symbol?

The stock symbol (or ticker) of Imunon Inc is IMNN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top